These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28862507)

  • 1. A "GLI-tch" in Alveolar Myofibroblast Differentiation.
    Ahlfeld SK; Perl AK
    Am J Respir Cell Mol Biol; 2017 Sep; 57(3):261-262. PubMed ID: 28862507
    [No Abstract]   [Full Text] [Related]  

  • 2. Surfactant palmitoylmyristoylphosphatidylcholine is a marker for alveolar size during disease.
    Ridsdale R; Roth-Kleiner M; D'Ovidio F; Unger S; Yi M; Keshavjee S; Tanswell AK; Post M
    Am J Respir Crit Care Med; 2005 Jul; 172(2):225-32. PubMed ID: 15879423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchopulmonary dysplasia and emphysema: in search of common therapeutic targets.
    Bourbon JR; Boucherat O; Boczkowski J; Crestani B; Delacourt C
    Trends Mol Med; 2009 Apr; 15(4):169-79. PubMed ID: 19303361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.
    Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X
    J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide causes pulmonary cell apoptosis and emphysema: a role for sphingolipid homeostasis in the maintenance of alveolar cells.
    Petrache I; Natarajan V; Zhen L; Medler TR; Richter A; Berdyshev EV; Tuder RM
    Proc Am Thorac Soc; 2006 Aug; 3(6):510. PubMed ID: 16921130
    [No Abstract]   [Full Text] [Related]  

  • 6. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
    Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
    Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
    Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Releasing Tensin.
    Horowitz JC
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):417-418. PubMed ID: 28362149
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
    Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
    Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The mechanism of lung tissue remodeling in the progression of idiopathic pulmonary fibrosis].
    Kogan EA; Tyong FV; Demura SA
    Arkh Patol; 2010; 72(4):30-6. PubMed ID: 21086635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myofibroblast contraction is essential for generating and regenerating the gas-exchange surface.
    Li R; Li X; Hagood J; Zhu MS; Sun X
    J Clin Invest; 2020 Jun; 130(6):2859-2871. PubMed ID: 32338642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Kobayashi K; Araya J; Minagawa S; Hara H; Saito N; Kadota T; Sato N; Yoshida M; Tsubouchi K; Kurita Y; Ito S; Fujita Y; Takasaka N; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Kojima J; Shimizu K; Numata T; Kawaishi M; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    J Immunol; 2016 Jul; 197(2):504-16. PubMed ID: 27279371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
    Zhu L; Fu X; Chen X; Han X; Dong P
    Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of myofibroblast dedifferentiation in pulmonary fibrosis.
    Ju X; Wang K; Wang C; Zeng C; Wang Y; Yu J
    Respir Res; 2024 Jul; 25(1):284. PubMed ID: 39026235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis.
    Wang C; Gu S; Cao H; Li Z; Xiang Z; Hu K; Han X
    Sci Rep; 2016 Jul; 6():30122. PubMed ID: 27444321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of all-trans-retinoic acid in promoting alveolar repair.
    Belloni PN; Garvin L; Mao CP; Bailey-Healy I; Leaffer D
    Chest; 2000 May; 117(5 Suppl 1):235S-41S. PubMed ID: 10843926
    [No Abstract]   [Full Text] [Related]  

  • 17. Lactate levels in airways of patients with cystic fibrosis and idiopathic pulmonary fibrosis.
    Worlitzsch D; Meyer KC; Döring G
    Am J Respir Crit Care Med; 2013 Jul; 188(1):111. PubMed ID: 23815725
    [No Abstract]   [Full Text] [Related]  

  • 18. STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.
    Pedroza M; Le TT; Lewis K; Karmouty-Quintana H; To S; George AT; Blackburn MR; Tweardy DJ; Agarwal SK
    FASEB J; 2016 Jan; 30(1):129-40. PubMed ID: 26324850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Interstitial Lung Disease: It's in the Mucus.
    Dickey BF; Whitsett JA
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):12-14. PubMed ID: 28665223
    [No Abstract]   [Full Text] [Related]  

  • 20. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective.
    Tuder RM; Yoshida T; Arap W; Pasqualini R; Petrache I
    Proc Am Thorac Soc; 2006 Aug; 3(6):503-10. PubMed ID: 16921129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.